Showing results (851-860 of 1,649) with videos related to

Sort By:
Pageof 165
Clinical and Translational Medicine|November 6, 2022
Blockade of the pentraxin 3/CD44 interaction attenuates lung injury-induced fibrosisJhih-Ying Chi, Yu-Wei Hsiao, Hsin-Yin Liang, et al.
Clinical and Translational Medicine|November 6, 2022
Single-cell RNA sequencing reveals cellular and molecular reprograming landscape of gliomas and lung cancer brain metastasesHe-Fen Sun, Liang-Dong Li, I-Weng Lao, et al.
Clinical and Translational Medicine|October 17, 2022
Single-cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myelomaXin Li, Mengping Chen, Yike Wan, et al.
Clinical and Translational Medicine|September 30, 2022
Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortalityRuth Pidsley, Dilys Lam, Wenjia Qu, et al.
Clinical and Translational Medicine|September 30, 2022
Inhibition of ROCK ameliorates pulmonary fibrosis by suppressing M2 macrophage polarisation through phosphorylation of STAT3Qingfang Li, Yuan Cheng, Zhe Zhang, et al.
Clinical and Translational Medicine|August 28, 2022
Translocation of gasdermin D induced mitochondrial injury and mitophagy mediated quality control in lipopolysaccharide related cardiomyocyte injuryZiqing Yu, Zilong Xiao, Lichun Guan, et al.
Clinical and Translational Medicine|October 17, 2015
Plasma preparation to measure FDA-approved protein markers by selected reaction monitoringOlga I Kiseleva, Yulia A Romashova, Natalia E Moskaleva, et al.
Clinical and Translational Medicine|October 18, 2018
Combination therapy to checkmate Glioblastoma: clinical challenges and advancesDebarati Ghosh, Saikat Nandi, Sonali Bhattacharjee
Clinical and Translational Medicine|April 9, 2019
A non-randomized clinical trial to evaluate the effect of fingolimod on expanded disability status scale score and number of relapses in relapsing-remitting multiple sclerosis patientsMehrdokht Mazdeh, Shahriar Kargar Monhaser, Mohammad Taheri, et al.
Clinical and Translational Medicine|July 31, 2018
Lipidomics: a promising cancer biomarkerFurong Yan, Hong Zhao, Yiming Zeng
Pageof 165